SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Total Revenues		$ 1,292	$ 110	$ 2,660	$ 1,087
Service [Member]
Disaggregation of Revenue [Line Items]
Total Revenues	[1]	548	105	843	317
Product [Member]
Disaggregation of Revenue [Line Items]
Total Revenues		$ 744	$ 5	$ 1,817	$ 770

[1] During the second quarter of 2022, the Company completed the development of a customer-specific project for a Fortune 500 multinational healthcare corporation and moved from the development phase of the project to its production phase. As a result, during the nine months ended September 30, 2024, the Company recognized development services revenues in the amount of $317 thousand and related development costs previously deferred in the amount of $180 thousand. The amounts were recognized based on the expected manufacturing term of the product, which the Company estimates at seven years.